Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| Dysgeusia | Dysgeusia | 4% | 1% | x | x | x | 
| Eructation | Eructation | 4% | 1% | x | x | x | 
| Dyspepsia | Dyspepsia | 3% | 2% | x | x | x | 
| Anaphylactic shock | Anaphylactic shock | postmarketing | x | x | x | |
| Haemorrhagic disorder | Haemorrhagic disorder | postmarketing | x | x | x | |
| Constipation | Constipation | x | x | x | ||
| Dermatitis | Rash | x | x | x | ||
| Rash | Rash | x | x | x | ||
| Gastrointestinal disorder | Gastrointestinal disorder | x | x | x | ||
| Pruritus | Pruritus | x | x | x | ||
| Vomiting | Vomiting | x | x | x | ||
| Aspartate aminotransferase increased | Aspartate aminotransferase increased | x | x | x | ||
| Alanine aminotransferase increased | Alanine aminotransferase increased | x | x | x | ||
| Malnutrition | Malnutrition | x | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |